Liver cirrhosis is a common long‑term outcome of chronic hepatic inflammation. Patients with
liver cirrhosis may also have pulmonary complications. There are several reasons for …

Portopulmonary hypertension (PoPH) refers to the condition that pulmonary arterial
hypertension (PAH) occur in the stetting of portal hypertension. The development of PoPH is …

Background: Liver transplant is the only definitive treatment for many patients with end stage
liver disease. Presence and severity of preoperative pulmonary disease directly affect the …

Methods: A cross-sectional study was done from April to June 2014 in 42 patients with
cirrhosis using a pre-tested semi-structured interview schedule. Results: There was no …

Results: A total of 64 (53 males and 11 females) patients with an average age of 49.82±9.89
years were studied. Alcoholism was the most common cause of cirrhosis in males …

JCM | Free Full-Text | Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor
Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis …

BACKGROUND AND OBEJECTIVE: Pulmonary arterial hypertension is a wellrecognized
entity in patients with cirrhosis of liver. Various studies have reported a prevalence varying …

Introduction: The chronic liver disease (CLD) patients usually develop portal hypertension
over a period of time. CLD may be associated with pulmonary vascular abnormality in the …

Background: Cirrhosis, as the end stage of a variety of chronic liver diseases, can affect
oxygenation in patients and make them hypoxic through hepatopulmonary syndrome or …

Background: Hepatopulmonary syndrome is characterized by clinical triad of chronic liver
disease, hypoxemia and intrapulmonary vascular dilatation. Routine screening of …